Differentiated thyroid cancers are typically iodine-avid and can be effectively treated with
radioiodine. In most patients, radioiodine treatment is done for ablation of residual tissue …

The incidence of differentiated thyroid cancer has increased worldwide over the last three
decades, but thyroid cancer-related mortality remains stable. Until recently, the standard …

Radioactive iodine therapy has evolved over the past 70 years from treatment of known
metastatic thyroid carcinoma to include adjuvant use to decrease the incidence of recurrent …

Radioiodine therapy is a matter of controversy because different opinions exist about its use
for differentiated thyroid carcinoma. The following article sheds light on the different opinions …

The treatment of differentiated thyroid cancer continues to move away from a 'one size fits
all'approach to a process of tailored therapeutic decision-making that incorporates disease …

Radioactive iodine (RAI) therapy with iodine-131 is performed in select cases of
differentiated thyroid cancer (DTC), typically for remnant ablation, adjuvant therapy, or …

Differentiated thyroid cancer is the most frequent type of thyroid cancer with an increasing
incidence in the last decades. The initial management is represented by surgical treatment …

OBJECTIVE. The paradigm of theranostics is based on tailoring therapy for the purpose of
optimizing outcomes. This principle is being applied to radioactive iodine therapy …

Introduction The purpose of the present guidelines on the radioiodine therapy (RAIT) of
differentiated thyroid cancer (DTC) formulated by the European Association of Nuclear …

Thefirst reports of radionuclide therapy for thyroid disease used 130I, but 131I rapidly
became the favoured radionuclide with beta-and gamma-ray emissions and a half-life …